NEW YORK - Oramed Pharmaceuticals Inc . (NASDAQ:ORMP), a clinical-stage pharmaceutical company with a market capitalization of $87 million, has announced the formation of a new joint venture, OraTech ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback